Morepen Laboratories Statistics

Total Valuation

Morepen Laboratories has a market cap or net worth of INR 41.44 billion. The enterprise value is 39.91 billion.

Market Cap	41.44B
Enterprise Value	39.91B

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Morepen Laboratories has 547.95 million shares outstanding. The number of shares has increased by 0.54% in one year.

Current Share Class	n/a
Shares Outstanding	547.95M
Shares Change (YoY)	+0.54%
Shares Change (QoQ)	+5.25%
Owned by Insiders (%)	9.36%
Owned by Institutions (%)	1.33%
Float	302.95M

Valuation Ratios

The trailing PE ratio is 29.94.

PE Ratio	29.94
Forward PE	n/a
PS Ratio	2.21
PB Ratio	3.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.65, with an EV/FCF ratio of -149.58.

EV / Earnings	30.40
EV / Sales	2.25
EV / EBITDA	20.65
EV / EBIT	21.78
EV / FCF	-149.58

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.03.

Current Ratio	2.69
Quick Ratio	1.20
Debt / Equity	0.03
Debt / EBITDA	0.17
Debt / FCF	-1.26
Interest Coverage	34.57

Financial Efficiency

Return on equity (ROE) is 13.88% and return on invested capital (ROIC) is 11.68%.

Return on Equity (ROE)	13.88%
Return on Assets (ROA)	8.31%
Return on Capital (ROIC)	11.68%
Revenue Per Employee	8.25M
Profits Per Employee	610,070
Employee Count	2,152
Asset Turnover	1.29
Inventory Turnover	4.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +95.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+95.25%
50-Day Moving Average	85.05
200-Day Moving Average	61.30
Relative Strength Index (RSI)	39.16
Average Volume (20 Days)	876,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Morepen Laboratories had revenue of INR 17.75 billion and earned 1.31 billion in profits. Earnings per share was 2.53.

Revenue	17.75B
Gross Profit	6.65B
Operating Income	1.83B
Pretax Income	1.80B
Net Income	1.31B
EBITDA	1.93B
EBIT	1.83B
Earnings Per Share (EPS)	2.53

Full Income Statement

Balance Sheet

The company has 1.86 billion in cash and 334.95 million in debt, giving a net cash position of 1.53 billion or 2.79 per share.

Cash & Cash Equivalents	1.86B
Total Debt	334.95M
Net Cash	1.53B
Net Cash Per Share	2.79
Equity (Book Value)	11.10B
Book Value Per Share	20.71
Working Capital	6.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 483.02 million and capital expenditures -749.82 million, giving a free cash flow of -266.80 million.

Operating Cash Flow	483.02M
Capital Expenditures	-749.82M
Free Cash Flow	-266.80M
FCF Per Share	-0.49

Full Cash Flow Statement

Margins

Gross margin is 37.48%, with operating and profit margins of 10.32% and 7.40%.

Gross Margin	37.48%
Operating Margin	10.32%
Pretax Margin	10.17%
Profit Margin	7.40%
EBITDA Margin	10.89%
EBIT Margin	10.32%
FCF Margin	-1.50%

Dividends & Yields

Morepen Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.54%
Shareholder Yield	-0.54%
Earnings Yield	3.34%
FCF Yield	-0.64%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a